Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples